Suppr超能文献

弥漫性大B细胞淋巴瘤的骨髓受累:氟代脱氧葡萄糖正电子发射断层扫描摄取与细胞浸润类型之间的相关性

Bone marrow involvement in diffuse large B-cell lymphoma: correlation between FDG-PET uptake and type of cellular infiltrate.

作者信息

Paone Gaetano, Itti Emmanuel, Haioun Corinne, Gaulard Philippe, Dupuis Jehan, Lin Chieh, Meignan Michel

机构信息

Department of Nuclear Medicine, Hôpital Henri Mondor, Assistance Publique-Hôpitaux de Paris (AP-HP), Université Paris 12, F-94000 Créteil, France.

出版信息

Eur J Nucl Med Mol Imaging. 2009 May;36(5):745-50. doi: 10.1007/s00259-008-1021-9. Epub 2008 Dec 19.

Abstract

PURPOSE

To assess, in patients with diffuse large B-cell lymphoma (DLBCL), whether the low sensitivity of (18)F-fluorodeoxyglucose positron emission tomography (FDG-PET) for bone marrow assessment may be explained by histological characteristics of the cellular infiltrate.

METHODS

From a prospective cohort of 110 patients with newly diagnosed aggressive lymphoma, 21 patients with DLBCL had bone marrow involvement. Pretherapeutic FDG-PET images were interpreted visually and semiquantitatively, then correlated with the type of cellular infiltrate and known prognostic factors.

RESULTS

Of these 21 patients, 7 (33%) had lymphoid infiltrates with a prominent component of large transformed lymphoid cells (concordant bone marrow involvement, CBMI) and 14 (67%) had lymphoid infiltrates composed of small cells (discordant bone marrow involvement, DBMI). Only 10 patients (48%) had abnormal bone marrow FDG uptake, 6 of the 7 with CBMI and 4 of the 14 with DBMI. Therefore, FDG-PET positivity in the bone marrow was significantly associated with CBMI, while FDG-PET negativity was associated with DBMI (Fisher's exact test, p=0.024). There were no significant differences in gender, age and overall survival between patients with CBMI and DBMI, while the international prognostic index was significantly higher in patients with CBMI.

CONCLUSION

Our study suggests that in patients with DLBCL with bone marrow involvement bone marrow FDG uptake depends on two types of infiltrate, comprising small (DBMI) or large (CBMI) cells. This may explain the apparent low sensitivity of FDG-PET previously reported for detecting bone marrow involvement.

摘要

目的

评估在弥漫性大B细胞淋巴瘤(DLBCL)患者中,(18)F-氟脱氧葡萄糖正电子发射断层扫描(FDG-PET)对骨髓评估的低敏感性是否可由细胞浸润的组织学特征来解释。

方法

在110例新诊断的侵袭性淋巴瘤患者的前瞻性队列中,21例DLBCL患者存在骨髓受累。对治疗前的FDG-PET图像进行视觉和半定量解读,然后将其与细胞浸润类型和已知的预后因素相关联。

结果

在这21例患者中,7例(33%)有以大的转化淋巴细胞为突出成分的淋巴样浸润(一致性骨髓受累,CBMI),14例(67%)有由小细胞组成的淋巴样浸润(不一致性骨髓受累,DBMI)。只有10例患者(48%)骨髓FDG摄取异常,7例CBMI患者中有6例,14例DBMI患者中有4例。因此,骨髓FDG-PET阳性与CBMI显著相关,而FDG-PET阴性与DBMI相关(Fisher精确检验,p=0.024)。CBMI和DBMI患者在性别、年龄和总生存期方面无显著差异,而CBMI患者的国际预后指数显著更高。

结论

我们的研究表明,在有骨髓受累的DLBCL患者中,骨髓FDG摄取取决于两种浸润类型,即由小细胞(DBMI)或大细胞(CBMI)组成。这可能解释了先前报道的FDG-PET检测骨髓受累时明显的低敏感性。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验